Roopa Industries Ltd.
Snapshot View

37.05 -1.85 ▼-4.8%

16 August 2022, 03:09:00 PM
Volume: 10,004

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.investorsatril.com
Market Cap 30.87 Cr.
Enterprise Value(EV) 39.05 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 1.29 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 30.42 Trailing Twelve Months Ending 2022-03
Industry PE 32.02 Trailing Twelve Months Ending 2022-03
Book Value / Share 16.00 Trailing Twelve Months Ending 2022-03
Price to Book Value 2.45 Calculated using Price: 39.25
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 0.79 Cr. 7,865,520 Shares
FaceValue 10
Company Profile
Roopa Industries is a part of the TGV Group, a reputed conglomerate in India, which manufactures and exports Chloro Alkali Products, Castor Oil Derivatives, Fatty Acids and Water Treatment Chemicals to various countries. The company is a manufacturer of Neutraceuticals, Fine chemicals, Drug Intermediates and Bulk Drugs since 1998.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-4.76%
1 Week
+15.06%
1 Month
+4.81%
3 Month
+29.77%
6 Month
+54.38%
1 Year
+136.29%
2 Year
+277.68%
5 Year
+212.92%
10 Year
+409.63%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 1.72 -21.14 1.88 1.96 2.07 5.63 5.97 3.51 6.41
Return on Capital Employed (%) 7.02 -4.35 9.25 10.06 10.27 6.44 8.63 8.67 8.06
Return on Assets (%) 0.79 -8.50 0.65 0.68 0.70 1.68 1.68 1.00 1.69

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 11 8 9 9 9 10 10 11 12 13
Non Curr. Liab. 3 4 4 6 8 11 10 9 9 5
Curr. Liab. 10 12 13 10 11 15 16 19 26 31
Minority Int.
Equity & Liab. 23 24 26 25 29 35 36 38 46 49
Non Curr. Assets 10 10 10 8 7 9 11 11 11 11
Curr. Assets 14 13 16 17 21 26 25 27 36 38
Misc. Exp. not W/O
Total Assets 23 24 26 25 29 35 36 38 46 49

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 32 29 31 31 30 19 30 28 27 47
Other Income 0 0 0 3 0 5 0 1 2 5
Total Income 32 29 31 34 30 24 30 29 29 51
Total Expenditure -30 -29 -29 -31 -28 -22 -28 -26 -26 -48
PBIDT 2 0 2 2 2 2 3 3 3 4
Interest -1 -1 -1 -1 -2 -1 -1 -1 -1 -1
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items 0 0
PAT 0 -2 0 0 0 1 1 0 1 1
Adjusted EPS 0 -3 0 0 0 1 1 0 1 1

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 1 -1 1 1 1 -1 -5 4 2 -1
Cash Fr. Inv. -1 -1 0 0 0 0 3 -2 1 1
Cash Fr. Finan. 0 1 0 0 -1 2 2 -2 -3 -1
Net Change 0 -1 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 1 1 0 0 0 0 0 0 0 1

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 48.03 48.03 48.03 48.03 48.03 48.03 48.03 48.03 48.03
Public 51.97 51.97 51.97 51.97 51.97 51.97 51.97 51.97 51.97
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Sat, 13 Aug 2022
Board Meeting Outcome for Submission Of Financial Results And Intimation Of Outcome Of The Board Meeting Held On 13Th August 2022
Submission of financial results for Quarter ended 30th June 2022 and intimation of Outcome of the Board Meeting held on 13th August 2022
Sat, 13 Aug 2022
Submission Of Financial Results For The Quarter Ended 30Th June 2022.
Submission of financial results for the quarter ended 30th June 2022.
Thu, 04 Aug 2022
Board Meeting Intimation for Intimation Regarding Board Meeting To Be Held On Saturday 13Th August 2022
ROOPA INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2022 inter alia to consider and approve Intimation regarding Board Meeting to be held on Saturday 13th August 2022 to consider and approve the Unaudited Financial Results for the 1st quarter ended on 30 June 2022

Technical Scans View Details >>

Fri, 12 Aug 2022
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,167.25 914.75 +0.1%
Divi's Laboratories Ltd. 98,918.90 3,728.00 +0.0%
Cipla Ltd. 82,906.37 1,035.20 +0.8%
Dr. Reddy's Laboratories Ltd. 70,920.35 4,300.40 +0.9%
Apollo Hospitals Enterprise Ltd. 62,010.73 4,353.00 +0.9%
Torrent Pharmaceuticals Ltd. 51,917.53 1,573.40 +2.2%
Piramal Enterprises Ltd. 45,855.65 1,924.95 +0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.35 914.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 33.43 3,728.00 +0.0%
Cipla Ltd. Consolidated 2022-06 33.32 1,035.20 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.69 4,300.40 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.15 4,353.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.82 1,573.40 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-06 24.38 1,924.95 +0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.37 914.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8.44 3,728.00 +0.0%
Cipla Ltd. Consolidated 2022-06 3.86 1,035.20 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.50 4,300.40 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.43 4,353.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.12 1,573.40 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,924.95 +0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 914.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,728.00 +0.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,035.20 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,300.40 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,353.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,573.40 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,924.95 +0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 914.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,728.00 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,035.20 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,300.40 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,353.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,573.40 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,924.95 +0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 914.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,728.00 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,035.20 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,300.40 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,353.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,573.40 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,924.95 +0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 914.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,728.00 +0.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,035.20 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,300.40 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,353.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,573.40 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,924.95 +0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 914.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,728.00 +0.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,035.20 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,300.40 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,353.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,573.40 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,924.95 +0.2%

FAQ's On Roopa Industries Ltd.

Can I Buy Roopa Industries Shares now?

What is the Share Price of Roopa Industries?

What is the Relative Strength Index (RSI) Value of Roopa Industries?

What is the Market Capital (MCAP) of Roopa Industries?

What are the key metrics to analyse Roopa Industries?

What is the Price Performance of Roopa Industries?